Inhibikase Therapeutics Price Chart
Inhibikase Therapeutics Volume Chart
Inhibikase Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
+0.04(+1.75%)
| Open | $2.28 |
|---|---|
| Close | $2.32 |
| Low | $2.28 |
| Low Change | 0.00 (0.00%) |
| High | $2.32 |
| High Change | +0.04 (+1.75%) |
| Range | $0.04 |
| Volume | 60.268K |
| Dollar Volume | $139.82K |
Regular Trading Hours
+0.08(+3.62%)
| Open | $2.21 |
|---|---|
| Close | $2.29 |
| Low | $2.19 |
| Low Change | -0.03 (-1.13%) |
| High | $2.32 |
| High Change | +0.11 (+4.98%) |
| Range | $0.14 |
| Volume | 324.322K |
| Dollar Volume | $742.70K |
Premarket
+0.00(+0.00%)
| Open | $2.16 |
|---|---|
| Close | $2.16 |
| Low | $2.16 |
| Low Change | 0.00 (0.00%) |
| High | $2.16 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1K |
| Dollar Volume | $2.16K |
After Hours Yesterday
-0.04(-1.78%)
| Open | $2.21 |
|---|---|
| Close | $2.17 |
| Low | $2.17 |
| Low Change | -0.04 (-1.78%) |
| High | $2.21 |
| High Change | +0.00 (+0.00%) |
| Range | $0.04 |
| Volume | 72.937K |
| Dollar Volume | $158.32K |
Regular Trading Hours Yesterday
-0.09(-3.90%)
| Open | $2.31 |
|---|---|
| Close | $2.22 |
| Low | $2.17 |
| Low Change | -0.14 (-6.06%) |
| High | $2.33 |
| High Change | +0.02 (+0.87%) |
| Range | $0.16 |
| Volume | 600.131K |
| Dollar Volume | $1.33M |
Premarket Yesterday
*No Trades in Segment
Inhibikase Therapeutics News
There is no current news for this stock at the moment.
Inhibikase Therapeutics Top Trades
Inhibikase Therapeutics's top trade so far today returned +7.63%, while the top short trade returned -1.72%.
Inhibikase Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.30 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.25 |
| 20 Day Moving Average (SMA20) | $2.14 |
| 50 Day Moving Average (SMA50) | $1.90 |
| 100 Day Moving Average (SMA100) | $1.86 |
| 200 Day Moving Average (SMA200) | $1.77 |
Inhibikase Therapeutics Statistics
| Average Volume (30 Days) | 1.08M |
|---|---|
| P/E Ratio (Current) | -6.91 |
| EPS (Current) | -$0.32 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$35.74M |
| Cash Ratio | 8.68 |
| Current Ratio | 30.14 |
| Quick Ratio | 30.14 |
| Debt to Equity | 0.00 |
| Enterprise Value | $297.47M |
| EV to EBITDA | -5.39 |
| EV to Sales | — |
| Price to Book | 2.07 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.29% |
| Return on Equity | -0.30% |
Inhibikase Therapeutics Stock Splits
There has been 1 stock split for Inhibikase Therapeutics (IKT). The reverse stock split occured on June 30, 2023 and reduced the outstanding shares at a ratio of 6:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 30, 2023 | Reverse | 6:1 |
Inhibikase Therapeutics Dividends
There have been no dividends for Inhibikase Therapeutics (IKT).